The renin–angiotensin system is usually associated with blood pressure homeostasis, and, yet, its impact on immunomodulation, which encompass various entities, such as cancer, septic shock, and transplantation, should warrant a physician’s awareness on potential therapeutic targets using readily available drugs. The gene discussed is REN; the disease is cancer.